To assess the efficacy of lanreotide in controling total liver volume in patients with
polycystic livers this study will be performed. A minimum of 38 patients will be recruited
and randomized (1:1) to receive either verum or placebo. Lanreotide is already used in other
disease states and found to be safe and non-toxic.